Mara
Stein.
This patient summary turns a longitudinal synthetic record into a readable clinical narrative, linking encounters, chronic conditions, medications, vitals, and family history in one review surface. Open the patient graph at any time to inspect the same record as connected evidence.
Dossier
Who the record describes
A 48-year-old woman followed at Rhein Main Medical Center across ten encounters. The chart opens with prediabetes, obesity, and family cardiac risk. Over two years the record resolves into four managed threads: type 2 diabetes, hypertension, dyslipidemia, and weight reduction. A paternal cardiac signal shapes the claims and risk context.
At a glance
The record begins, as these records do, in routine.
Ms. Stein arrives for an intake visit. The chart notes BMI 34.8 and blood pressure 138 / 86, the first numbers in this volume that will matter later. She feels well, but her labs show HbA1c 6.2 and LDL 146, enough for the practice to start a prevention conversation.
The clinician is Dr. Weber. She orders repeat HbA1c, a lipid panel, and a nutrition referral. She mentions metformin as a likely next step if the trend worsens.
The diagnosis that had been forming gets written down.
Labs return. HbA1c 7.1. LDL 158. Blood pressure holds at 144 / 88. Dr. Weber enters two problems onto the chart: type 2 diabetes mellitus and essential hypertension. The conversation that was hypothetical in December becomes a plan.
One prescription is started. Metformin ER 500mg nightly, with escalation planned if tolerated. Atorvastatin is discussed but deferred for a lifestyle trial. A referral to a registered dietitian is sent. The patient asks about her father, who had a myocardial infarction at 61. Dr. Weber adds a note to revisit cardiovascular risk after the next lab cycle.
A small win in the first numbers back.
A telehealth visit. Home readings show blood pressure averaging 132 / 84 across the last two weeks. The patient reports mild GI upset on metformin that resolved after a week. The dose is titrated to 1000mg twice daily. A 15-minute conversation about carbohydrate density at dinner, which he finds useful.
An interruption. A productive cough, seven days in.
Sinusitis with lower-respiratory overlap. Temperature 100.9°F. The chart notes clear chest on auscultation. A short course of doxycycline is prescribed for seven days, plus a albuterol inhaler as needed for wheeze. The metabolic and cardiovascular maintenance continues unchanged.
The first screening turns up something small and clean.
A routine age-based colonoscopy. One 6mm tubular adenoma is excised cleanly. Pathology is benign. The recommendation is to repeat in five years. The family-history flag for cancer is cross-referenced and noted as breast rather than colorectal, and the screening interval stays standard.
The steadiest page in the record.
Both chronic numbers are now inside target. HbA1c is 6.8. Blood pressure 126 / 80. Weight is down nine pounds from the annual. The patient is walking forty minutes a day on most weekdays. No medication changes. A reminder is entered for a lipid panel at the next visit.
A year after the diagnoses, the arc closes on a plateau.
All numbers hold. Lipids are improved, LDL 118, without adding a statin, though the plan notes it as a live conversation. Dr. Weber documents "well-controlled chronic disease, engaged patient" and sets the next check-in at six months.
The record, at this page, is a readable arc: a signal, a diagnosis, a plan, and a year of compliance that bent the numbers the right way. The chart is kept current. The family-history flag remains, quietly, on the margin.
Three years of weight.
One of the few numbers that shows up at every visit. Read top to bottom.
Every condition, in one frame.
Active, resolved, and in-the-margin. Click any card to open it in the map.
Type 2 Diabetes Mellitus
Diagnosed Apr 2023. HbA1c trended from 7.1 to 5.9 across the synthetic journey on metformin and lifestyle change.
Essential Hypertension
Diagnosed Apr 2024. Stable 122/74 on lisinopril 5mg daily. No end-organ concerns.
Acute Bronchitis
Jan 2024. Treated with doxycycline for 7 days and albuterol as needed. Full resolution.
Overweight / Obesity, Class I
BMI 31.4 at chart open. Sustained weight loss of 9 lb across 16 months. Remains in Class I.
Dyslipidaemia
LDL peaked 164 Apr '24; 118 Apr '25. Statin remains a planned conversation, not started.
The pharmacy ledger.
Four drugs, read chronologically. Two are long-term. Two answered a cold.
The family column.
Three relatives. Metabolic and cardiovascular risk signals are separated from encounter detail.
Type 2 diabetes
Longstanding diabetes. This background risk makes the patient''s metabolic arc easier to understand in context.
Type 2 diabetes, hypertension
Diagnosed in mid-60s; same two conditions the patient now carries. A concordant metabolic arc, one generation on.
No significant history
Alive, well, 49y. Noted for completeness.
Open the map.
Every encounter, condition, medication, family signal, and provider is a node. Click to follow the threads. Press Esc to come back to the story.